Cargando…

Prazosin dosed 3 times a day to treat flashbacks related to PTSD: A case report

Prazosin is an alpha-1 adrenergic receptor antagonist widely known by mental health providers for its off-label use for nightmares in patients with PTSD. Prazosin is lipophilic and crosses the blood-brain barrier to antagonize alpha-1 receptors in the central nervous system, potentially reducing aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Christie, Swartz, Alexander, Forsberg, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association of Psychiatric Pharmacists 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405631/ https://www.ncbi.nlm.nih.gov/pubmed/36071742 http://dx.doi.org/10.9740/mhc.2022.08.267

Ejemplares similares

Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD
por: Fisher, Kristy A., et al.
Publicado: (2022)

Case series: Continued remission of PTSD symptoms after discontinuation of prazosin
por: Richardson, Christie, et al.
Publicado: (2023)

Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents
por: Hudson, Nancy, et al.
Publicado: (2021)

Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD
por: McCall, William Vaughn, et al.
Publicado: (2019)

Flashback
por: Zhao, Rebecca
Publicado: (2020)

The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related Clustering
por: Hendrickson, Rebecca C., et al.
Publicado: (2021)

Re-experiencing traumatic events in PTSD: new avenues in research on intrusive memories and flashbacks
por: Brewin, Chris R.
Publicado: (2015)

Flashback : la aventura del periodismo musical /
por: Blanc, Enrique
Publicado: (2012)

Virginia en flashback
por: Conteris, Hiber
Publicado: (1966)

Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review
por: Keeshin, Brooks R., et al.
Publicado: (2017)

PS256. New drug therapy and the effect mechanism that the central anticholinergic drug Trihexylphenidyl reduces flashback in PTSD. The second report
por: Katsumasa, Sogo
Publicado: (2016)

An fMRI investigation of posttraumatic flashbacks
por: Whalley, Matthew G., et al.
Publicado: (2013)

Flashbacks in social anxiety disorder: Psychopathology of a case
por: Kummer, Arthur, et al.
Publicado: (2008)

The neural basis of flashback formation: the impact of viewing trauma
por: Bourne, C., et al.
Publicado: (2013)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

Prazosin, Scorpion Sting and Dr. Bawaskar
por: Siva Sankara Murty, Yerramilli V.
Publicado: (2012)

Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review
por: Paiva, Henrique Soares, et al.
Publicado: (2021)

Frozen moments: flashback memories of critical incidents in emergency personnel
por: Kleim, Birgit, et al.
Publicado: (2015)

Source memory errors associated with reports of posttraumatic flashbacks: A proof of concept study
por: Brewin, Chris R., et al.
Publicado: (2012)

Prazosin initiation and dose titration in a patient with posttraumatic stress disorder on concurrent carvedilol
por: Khaw, Chelsea, et al.
Publicado: (2019)

Prazosin inhibits the growth and mobility of osteosarcoma cells
por: An, Ming, et al.
Publicado: (2019)

Prazosin for the management of behavioural and psychological symptoms of dementia
por: Tampi, Rajesh R, et al.
Publicado: (2022)

Flashback and lessons learnt from history of pandemics before COVID-19
por: Parihar, Shivay, et al.
Publicado: (2021)

Pain flashbacks: The role of intrusive pain symptoms in posttraumatic chronic pain
por: Tsur, N., et al.
Publicado: (2023)

Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder
por: Guo, Ping, et al.
Publicado: (2022)

Lead Poisoning-Induced Hypertensive Crisis Managed by Prazosin: A Case Report
por: Dadpour, Bita, et al.
Publicado: (2013)

The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.
por: Burney, I. A., et al.
Publicado: (1991)

Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction
por: Mandel, Erin R., et al.
Publicado: (2016)

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
por: Müller, Felix, et al.
Publicado: (2022)

Facial talon cusp: A rarity, report of a case with one year follow up and flashback on reported cases
por: Kulkarni, Vinaya Kumar, et al.
Publicado: (2012)

Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2011)

Prazosin during threat discrimination boosts memory of the safe stimulus
por: Homan, Philipp, et al.
Publicado: (2017)

Investigation of the Atypical Glass Transition and Recrystallization Behavior of Amorphous Prazosin Salts
por: Kumar, Lokesh, et al.
Publicado: (2011)

ODP032 Case Series: Prazosin in the Preoperative Management of Pheochromocytoma and Paraganglioma
por: Barreiro, Margarita, et al.
Publicado: (2022)

Prevalence of pain flashbacks in posttraumatic stress disorder arising from exposure to multiple traumas or childhood traumatization
por: Macdonald, B., et al.
Publicado: (2018)

Antagonistic Effects of Atipamezole, Yohimbine and Prazosin on Medetomidine-Induced Diuresis in Healthy Cats
por: MURAHATA, Yusuke, et al.
Publicado: (2013)

DEVELOPMENT OF NOVEL, ALTERNATIVE, FACILE, ECOFRIENDLY, HIGH YIELD SYNTHETIC PROCESS FOR PRAZOSIN
por: Patil, D. A., et al.
Publicado: (2010)

The Specific α1-Adrenergic Receptor Antagonist Prazosin Influences the Urine Proteome
por: Zhao, Mindi, et al.
Publicado: (2016)

The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model
por: Ketenci, Sema, et al.
Publicado: (2020)

Four Days Exposure And Reprocessing Therapy For PTSD
por: Duek, O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l2guv609rebl1mu9ieb55vd78b